PIP₃ is endocytosed via a constitutive endocytotic pathway at growth cones. by Toshiyuki Kakumoto (442673)

Obesity Increases Airway Hyperresponsiveness via the TNF-α Pathway and Treating Obesity Induces Recovery by Joo Young Kim (128707)

“…Both the TNF-α blockade and depletion of alveolar macrophages in the DIO-OVA mice decreased AHR compared to the DIO-OVA mice. Treating obesity by exercise or through dietary means also reduced pulmonary TNF-α levels and AHR in the DIO-OVA mice. …”

PRRSV targets GRP78 for proteasomal degradation via viral glycoprotein GP2a. by Peng Gao (35465)

The phase plane for the dynamics of TE load. by Ronald D. Smith (7877330)

The phosphorylation status of RssB does not impact RpoS recovery from phosphate starvation. by Sophie Bouillet (18137403)

Volcano plot showing the results of the RESP contrast for the peripheral blood mononuclear cell (PBMC) samples at 34 days post-infection (dpi). by Gillian P. McHugo (8965919)

Flowchart of study participants. by Masoumeh Sayahi (17468290)

“…</p><p>Conclusion</p><p>Our study showed that Camellia sinensis extract ointment has a small effect on the healing process and pain reduction of episiotomy wounds. to confirm its effect, a study with a larger sample size should be conducted.…”

RpoS degradation quickly resumes after phosphate starvation. by Sophie Bouillet (18137403)

Predictability depends on visual stimulation and stimulus selectivity, while timescales are rather invariant. by Lucas Rudelt (4059505)

Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. by Gillian P. McHugo (8965919)

Mixed multivariable linear regression model for risk factors influencing Perceived Emotional Closeness between owners of 21-month-old Pandemic Puppies bought as puppies under 16-we... by Bree L. Merritt (20714798)

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Table1_IgE and IgG4 epitopes of the peanut allergens shift following oral immunotherapy.xlsx by Ian M. Rambo (6820001)

“…</p>Methods<p>Pre- and post- trial participant sera were collected approximately 12 months apart and tested for IgE binding to intact peanut proteins via ImmunoCAP ISAC immunoassays. IgE and IgG4 linear epitopes were identified based on binding to synthetic overlapping 15-mer linear peptides of 10 peanut allergens (Ara h 1-11) synthesized on microarray slides.…”